Aurora Cannabis appoints new chief financial officer, consolidates shares
Aurora Cannabis appointed Simona King, a veteran executive of multinational pharmaceutical company Bristol Myers Squibb, as chief financial officer.
Aurora Cannabis appointed Simona King, a veteran executive of multinational pharmaceutical company Bristol Myers Squibb, as chief financial officer.
MJBizDaily asked six experts from across the country to answer the question: Why isn’t Canada’s cannabis market thriving? Here’s what they said …
British Columbia is allowing certain license holders to promote outdoor cannabis consumption areas in a bid to improve hospitality and tourism business opportunities for the industry.
Ukraine President Volodymyr Zelenskyy has signed the country’s medical cannabis legislation into law, setting the legal stage for the creation of Europe’s newest medical market.
Canadian cannabis producer Organigram Holdings is eyeing international investment opportunities with its new war chest of capital, and the company will focus those efforts largely on the U.S. market, CEO Beena Goldenberg says.
Christina Lake Cannabis Corp. has acquired ownership of outdoor cultivation facilities in Midway, southern British Columbia, from an unidentified privately owned corporation for 3 million Canadian dollars ($2.2 million).
Thousands of cannabis businesses in Thailand are bracing for major legal and regulatory changes as the country looks to curb adult-use sales and pivot the industry back to a medicinal market.
Canadian cannabis producer Canopy Growth on Friday reported a shake-up to its board of directors, a lower third-quarter loss and a “singular focus” on marijuana.
Seattle-based Jones Soda Co. is partnering with licensed producer Tilray Brands to bring infused-beverage brand Mary Jones to the Canadian market, starting in Ontario.
Aurora Cannabis has acquired the remaining 90% equity interest of MedReleaf Australia it didn’t already own, giving the Canadian marijuana producer a bigger foothold in one of the world’s biggest federally regulated medical markets.
MediPharm Labs Corp.’s facility in Barrie, Ontario, received Good Manufacturing Practice (GMP) certification from Brazil’s National Sanitary Surveillance Agency for the production of finished cannabis goods.
German medical cannabis company Avextra closed a funding round totaling more than 20 million euros ($21.5 million).